{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T07:43:58Z","timestamp":1770623038272,"version":"3.49.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1097\/wno.0b013e31825103cb","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T06:35:30Z","timestamp":1335854130000},"page":"202-206","source":"Crossref","is-referenced-by-count":15,"title":["Prevalence of Diabetes Mellitus in Biopsy-Positive Giant Cell Arteritis"],"prefix":"10.1097","volume":"32","author":[{"given":"Jared L.","family":"Matthews","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David N.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley K.","family":"Farris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Michael","family":"Siatkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0889-857X(05)70232-5","article-title":"Epidemiology of the vasculitides.","volume":"27","author":"Gonzalez-Gay","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"issue":"suppl 2","key":"R2-3-20210126","first-page":"SII","article-title":"Epidemiology of giant-cell arteritis.","volume":"69","author":"Hunder","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"R3-3-20210126","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients.","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0","article-title":"Association between strong inflammatory response and low risk of developing visual loss and other cranial ischemic complications in giant cell (temporal) arteritis.","volume":"41","author":"Cid","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0161-6420(93)31608-8","article-title":"Visual prognosis in giant cell arteritis.","volume":"100","author":"Aiello","year":"1993","journal-title":"Ophthalmology"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0161-6420(94)31102-X","article-title":"Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.","volume":"101","author":"Liu","year":"1994","journal-title":"Ophthalmology"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z","article-title":"Permanent visual loss and cerebrovascular accidents in giant cell arteritis.","volume":"41","author":"Gonzalez-Gay","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMra022694","article-title":"Medium- and large-vessel vasculitis.","volume":"349","author":"Weyand","year":"2003","journal-title":"N Engl J Med"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.ophtha.2010.10.002","article-title":"Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy.","volume":"118","author":"Walvick","year":"2011","journal-title":"Ophthalmology"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0161-6420(02)01076-X","article-title":"Thrombocytosis in patients with biopsy-proven giant cell arteritis.","volume":"109","author":"Foroozan","year":"2002","journal-title":"Ophthalmology"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00041327-200020020-00001","article-title":"Thrombocytosis in temporal arteritis. Rising platelet counts: a red flag for giant cell arteritis.","volume":"20","author":"Lincoff","year":"2002","journal-title":"J Neuroophthalmol"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"812","DOI":"10.2337\/diabetes.52.3.812","article-title":"Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.","volume":"52","author":"Spranger","year":"2003","journal-title":"Diabetes"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"968","DOI":"10.7326\/0003-4819-67-5-968","article-title":"Ophthalmoplegia in diabetes mellitus.","volume":"67","author":"Zorilla","year":"1967","journal-title":"Ann Intern Med"},{"key":"R15-3-20210126","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.archoralbio.2010.03.021","article-title":"Trigeminal pain and quantitative sensory testing in painful peripheral diabetic neuropathy.","volume":"55","author":"Arap","year":"2010","journal-title":"Arch Oral Biol"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/01.md.0000145369.25558.b5","article-title":"Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis.","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X","article-title":"Giant cell arteritis and cardiovascular risk factors.","volume":"41","author":"Duhaut","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/ard.58.6.335","article-title":"Groupe de Recherche sur lArterite A Cellules Geantes. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease.","volume":"58","author":"Duhaut","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0002-9343(97)00117-4","article-title":"Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica.","volume":"102","author":"Rodriguez-Valverde","year":"1997","journal-title":"Am J Med"},{"key":"R20-3-20210126","first-page":"92","article-title":"Does this patient have temporal arteritisJAMA.","volume":"287","author":"Smetana","year":"2002","journal-title":""},{"key":"R21-3-20210126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/03009740600991646","article-title":"Proposal to decrease the number of negative temporal artery biopsies.","volume":"36","author":"Rodriguez-Pla","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/ard.46.4.282","article-title":"Clinical usefulness of temporal artery biopsy.","volume":"46","author":"Vilaseca","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/archinte.1992.00400200120022","article-title":"Presenting features and outcomes in patients undergoing temporal artery biopsy: a review of 98 patients.","volume":"152","author":"Chmelewski","year":"1992","journal-title":"Arch Intern Med"},{"key":"R24-3-20210126","first-page":"93","article-title":"The use of clinical characteristics to predict the results of temporal artery biopsy among patients with suspected giant cell arteritis.","volume":"22","author":"Gabriel","year":"1995","journal-title":"J Rheumatol"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/archopht.1983.01040020253019","article-title":"The clinical value of negative temporal artery biopsy specimens.","volume":"101","author":"Hedges","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/003693307902400203","article-title":"Temporal arteritis: a 14-year epidemiological, clinical, and prognostic study.","volume":"24","author":"Jonasson","year":"1979","journal-title":"Scott Med J"},{"key":"R27-3-20210126","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/art.23114","article-title":"Atherosclerosis in patients with biopsy-proven giant cell arteritis.","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"372","DOI":"10.5694\/j.1326-5377.1980.tb134927.x","article-title":"Giant cell arteritis: a five-year review of biopsy-proven cases in a teaching hospital.","volume":"1","author":"Dare","year":"1980","journal-title":"Med J Aust"},{"key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000070631","article-title":"Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.","volume":"217","author":"Hayreh","year":"2003","journal-title":"Opthalmologica"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1478-7954-7-16","article-title":"Diabetes prevalence and diagnosis in US states: analysis of health surveys.","volume":"7","author":"Danaei","year":"2009","journal-title":"Popul Health Metr"},{"key":"R31-3-20210126","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.20083","article-title":"Large-vessel vasculitis.","volume":"51","author":"Seo","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ophtha.2011.01.054","article-title":"Incidence of nonarteritic anterior ischemic optic neuropathy: increased risk among diabetic patients.","volume":"118","author":"Lee","year":"2011","journal-title":"Ophthalmology"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic.","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"R34-3-20210126","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archopht.1984.01040030721028","article-title":"The ultimate diagnoses of patients undergoing temporal artery biopsies.","volume":"102","author":"Roth","year":"1984","journal-title":"Arch Ophthalmol"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1568-9972(03)00064-8","article-title":"Immunopathways in giant cell arteritis and polymyalgia rheumatica.","volume":"3","author":"Weyand","year":"2004","journal-title":"Autoimmun Rev"},{"key":"R36-3-20210126","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease.","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"R37-3-20210126","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis.","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R38-3-20210126","first-page":"1103","article-title":"Negative temporal artery biopsies: eventual diagnoses and features of patients with biopsy-negative giant cell arteritis compared to patients without arteritis.","volume":"26","author":"Breuer","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"R39-3-20210126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F","article-title":"Disease pattern in cranial and large-vessel giant cell arteritis.","volume":"42","author":"Brack","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R40-3-20210126","first-page":"635","article-title":"Pathogenesis of giant cell arteritis: more than just an inflammatory conditionAutoimmun Rev.","volume":"9","author":"Ly","year":"2010","journal-title":""},{"key":"R41-3-20210126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/JCM.15.1.109-114.1982","article-title":"Impaired response of lymphocytes from non-insulin dependent diabetics to staphage lysate and tetanus antigen.","volume":"15","author":"Casey","year":"1982","journal-title":"J Clin Microbiol"},{"key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2005.02.009","article-title":"Toll-like receptors in giant cell arteritis.","volume":"115","author":"Ma-Krupa","year":"2005","journal-title":"Clin Immunol"}],"container-title":["Journal of Neuro-Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/WNO.0b013e31825103cb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:43:25Z","timestamp":1620978205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00041327-201209000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/wno.0b013e31825103cb","relation":{},"ISSN":["1070-8022"],"issn-type":[{"value":"1070-8022","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}